Share:
Corvus Pharmaceuticals (NASDAQ: CRVS) shares are trading lower Friday after the company priced its 8.571 million share common stock offering at $3.50 per share.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing small-molecule and antibody agents that target the immune system to treat patients with cancer. The firm s pipeline includes CPI-006, CPI-818, CPI-935, and others.
Corvus Pharmaceuticals shares were trading down 10.15% at $3.54. The stock has a 52-week high of $6.88 and a 52-week low of $1.01.
CollPlant (NASDAQ: CLGN) shares are trading lower after the company priced its registered direct offering of 2 million american depositary shares at $17.50 per ADS.